Evidence map›Paper›PMID 19103880›Full record

ArticleThe Journal of experimental medicine2009

B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase.

Annaiah Cariappa, Hiromu Takematsu, Haoyuan Liu, Sandra Diaz, Khaleda Haider, Cristian Boboila, Geetika Kalloo, Michelle Connole, Hai Ning Shi, Nissi Varki and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 125 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. PHF19 inhibition as a therapeutic target in multiple myeloma.Current research in translational medicine · 2021
    Article
  18. Review
  19. Article
  20. Expression of 9-mBio · 2019
    Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Annaiah CariappaMassachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA.
Hiromu Takematsu
Haoyuan Liu
Sandra Diaz
Khaleda Haider
Cristian Boboila
Geetika Kalloo
Michelle Connole
Hai Ning Shi
Nissi Varki
Ajit Varki
Shiv Pillai
Harvard University · USUniversity of California, San Diego · USMassachusetts General Hospital · US

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Siglec Modulation of Inflammation in Humans and MiceP01HL057345 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ESKO, JEFFREY D · 1997 to 2012
$24.1M
BIOSYNTHESIS AND REGULATION OF SUBSTITUTED SIALIC ACIDSR01GM032373 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI VARKI, AJIT P · 1985 to 2022
$6.9M
Studies on Peripheral B Lymphocyte DevelopmentR01AI064930 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI PILLAI, SHIV SUBRAMANIAM · 2006 to 2016
$3.9M
BIOLOGY OF SIALIC ACIDS AND THEIR SUBSTITUTIONSR37GM032373 · NIGMS · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI VARKI, AJIT P · 1995 to 2004
$1.8M
Molecular identification of a sialyl 9-O-acetyl transferaseR21AI069458 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI PILLAI, SHIV SUBRAMANIAM · 2007 to 2008
$477k
NHLBI NIH HHS P01 HL057345NHLBI NIH HHS P01HL057345NIAID NIH HHS AI064930NIAID NIH HHS AI069458NIAID NIH HHS R01 AI064930NIAID NIH HHS R21 AI069458NIDDK NIH HHS P30 DK043351NIGMS NIH HHS GM32373NIGMS NIH HHS R01 GM032373NIGMS NIH HHS R37 GM032373
6 · The paper itself

Abstract

We show that the enzymatic acetylation and deacetylation of a cell surface carbohydrate controls B cell development, signaling, and immunological tolerance. Mice with a mutation in sialate:O-acetyl esterase, an enzyme that specifically removes acetyl moieties from the 9-OH position of alpha2-6-linked sialic acid, exhibit enhanced B cell receptor (BCR) activation, defects in peripheral B cell development, and spontaneously develop antichromatin autoantibodies and glomerular immune complex deposits. The 9-O-acetylation state of sialic acid regulates the function of CD22, a Siglec that functions in vivo as an inhibitor of BCR signaling. These results describe a novel catalytic regulator of B cell signaling and underscore the crucial role of inhibitory signaling in the maintenance of immunological tolerance in the B lineage.

Indexed as

AcetylationAcetylesteraseAnimalsAntibodies, AntinuclearBlotting, WesternB-LymphocytesB-Lymphocyte SubsetsBone Marrow CellsCarboxylic Ester HydrolasesCell CountCell DifferentiationGlomerulonephritisMiceMice, Inbred C57BLMice, Inbred StrainsMice, KnockoutAcetylesteraseAntibodies, AntinuclearCarboxylic Ester HydrolasesCd22 protein, mouseProtein Tyrosine Phosphatase, Non-Receptor Type 6Ptpn6 protein, mouseReceptors, Antigen, B-Cellsialate O-acetylesteraseSialic Acid Binding Ig-like Lectin 2Sialic Acids

Identifiers

PMID19103880
PMCPMC2626685
OpenAlexW2115414456

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.